MedPath

Incidence and Clinical Characteristics of Pulmonary Hypertension Secondary to ARDS in the Highland

Conditions
ARDS
Registration Number
NCT05166759
Lead Sponsor
Southeast University, China
Brief Summary

The study is conducted in the affiliated hospital of Qinghai University .Patients in the department of Critical Care Medicine and Emergency Intensive Care Unit will be eligible for inclusion if they meet the Berlin criteria.Two researchers assess pulmonary artery pressure and right heart function of patients who are enrolled.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria

Inclusion Criteria:

18 to 80 years of age Meet the diagnostic criteria Receive invasive mechanical ventilation within 48 hours

Exclusion Criteria

Patients with those disease will be excluded : chronic obstructive pulmonary disease Pulmonary embolism Chronic heart failure Idiopathic pulmonary fibrosis Pulmonary hypertension Pregnant women will be excluded too.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
28-days mortality rate20/11/2021-20/12/2022

Mortality at 28 days of hospitalization

Incidence of Pulmonary Hypertension Secondary to ARDS in the Highland20/11/2021-20/12/2022
ICU mortality ICU mortality20/11/2021-20/12/2022

Mortality during treatment in ICU

Secondary Outcome Measures
NameTimeMethod
Ventilator time20/11/2021-20/12/2022

Ventilator time in ICU

Hospital length of stay20/11/2021-20/12/2022

Total length of stay in hospital

Trial Locations

Locations (1)

Affiliated Hospital of QingHai University

🇨🇳

Xining, Qinghai, China

© Copyright 2025. All Rights Reserved by MedPath